Literature DB >> 20044975

(15)N Solid-state NMR spectroscopic studies on phospholamban at its phosphorylated form at ser-16 in aligned phospholipid bilayers.

Shidong Chu1, Shadi Abu-Baker, Junxia Lu, Gary A Lorigan.   

Abstract

Wild-type phospholamban (WT-pan class="Gene">PLB) is a pentameric transmembrane protein that regulates the cardiac cycle (contraction and relaxation). From a physiological prospective, unphosphorylated WT-PLB inhibits sarcoplasmic reticulum ATPase activity; whereas, its phosphorylated form relieves the inhibition in a mechanism that is not completely understood. In this study, site-specifically (15)N-Ala-11- and (15)N-Leu-7-labeled WT-PLB and the corresponding phosphorylated forms (P-PLB) were incorporated into 1,2-dioleoyl-sn-glycero-3-phosphocholine/2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPC/DOPE) mechanically oriented lipid bilayers. The aligned (15)N-labeled Ala-11 and Leu-7 WT-PLB samples show (15)N resonance peaks at approximately 71ppm and 75ppm, respectively, while the corresponding phosphorylated forms P-PLB show (15)N peaks at 92ppm and 99ppm, respectively. These (15)N chemical shift changes upon phosphorylation are significant and in agreement with previous reports, which indicate that phosphorylation of WT-PLB at Ser-16 alters the structural properties of the cytoplasmic domain with respect to the lipid bilayers. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044975      PMCID: PMC2827642          DOI: 10.1016/j.bbamem.2009.12.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  58 in total

1.  Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56.

Authors:  P Henklein; R Kinder; U Schubert; B Bechinger
Journal:  FEBS Lett       Date:  2000-10-06       Impact factor: 4.124

2.  Molecular dynamics simulations reveal a disorder-to-order transition on phosphorylation of smooth muscle myosin.

Authors:  L Michel Espinoza-Fonseca; David Kast; David D Thomas
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

3.  The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces.

Authors:  Jonathan C Clayton; Eleri Hughes; David A Middleton
Journal:  Biochemistry       Date:  2005-12-27       Impact factor: 3.162

4.  Spectroscopic validation of the pentameric structure of phospholamban.

Authors:  Nathaniel J Traaseth; Raffaello Verardi; Kurt D Torgersen; Christine B Karim; David D Thomas; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

5.  Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation.

Authors:  J Zamoon; F Nitu; C Karim; D D Thomas; G Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

6.  Investigating the dynamic properties of the transmembrane segment of phospholamban incorporated into phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy.

Authors:  Elvis K Tiburu; Ethan S Karp; Paresh C Dave; Krishnan Damodaran; Gary A Lorigan
Journal:  Biochemistry       Date:  2004-11-09       Impact factor: 3.162

7.  Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase.

Authors:  Eleri Hughes; David A Middleton
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

8.  Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits.

Authors:  A D Wegener; L R Jones
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

9.  Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum.

Authors:  H K Simmerman; D E Lovelace; L R Jones
Journal:  Biochim Biophys Acta       Date:  1989-08-31

Review 10.  Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase.

Authors:  Nathaniel J Traaseth; Kim N Ha; Raffaello Verardi; Lei Shi; Jarrod J Buffy; Larry R Masterson; Gianluigi Veglia
Journal:  Biochemistry       Date:  2007-12-15       Impact factor: 3.162

View more
  5 in total

1.  Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport.

Authors:  Vitaly V Vostrikov; Kaustubh R Mote; Raffaello Verardi; Gianluigi Veglia
Journal:  Structure       Date:  2013-10-24       Impact factor: 5.006

2.  Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method.

Authors:  Raffaello Verardi; Lei Shi; Nathaniel J Traaseth; Naomi Walsh; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Christine B Karim; Elizabeth L Lockamy; David D Thomas; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

4.  Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump.

Authors:  John Paul Glaves; Catharine A Trieber; Delaine K Ceholski; David L Stokes; Howard S Young
Journal:  J Mol Biol       Date:  2010-11-23       Impact factor: 5.469

5.  Secondary structure, backbone dynamics, and structural topology of phospholamban and its phosphorylated and Arg9Cys-mutated forms in phospholipid bilayers utilizing 13C and 15N solid-state NMR spectroscopy.

Authors:  Xueting Yu; Gary A Lorigan
Journal:  J Phys Chem B       Date:  2014-02-18       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.